首页> 外文期刊>The journal of trauma and acute care surgery >Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy
【24h】

Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy

机译:严重伤害和早期创伤性凝血病患者的内皮糖萼降解诱导内源性肝素化

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: There is emerging evidence that early trauma-induced coagulopathy (TIC) is mechanistically linked to disruption of the vascular endothelium and its glycocalyx, assessed by thrombomodulin and syndecan 1, respectively. This study evaluated if degradation of the endothelial glycocalyx and ensuing release of its heparin-like substances induce autoheparinization and thereby contributes to TIC. METHODS: Prospective observational study of 77 trauma patients admitted to a Level I trauma center having blood sampled at admission. Data on demography, hematology, Injury Severity Score, transfusion requirements, 30-day mortality, and thrombelastography (TEG, concurrent kaolin-activated/kaolin-heparinase-activated) were recorded. Retrospective analysis of plasma/serum for biomarkers reflecting endothelial glycocalyx and cell damage (syndecan 1, thrombomodulin), tissue injury (histone-complexed DNA fragments), sympathoadrenal activation (adrenaline, noradrenaline), coagulation activation/anticoagulation (prothrombin fragment 1+2, fibrinogen, von Willebrand factor, factor XIII, antithrombin, protein C, activated protein C, tissue factor pathway inhibitor), fibrinolysis (tissue-type plasminogen activator, plasminogen activator inhibitor 1) and inflammation (interleukin 6, terminal complement complex). Stratification of patients was according to the degree of TEG-measured heparinization. RESULTS: Four patients (5.2%) displayed evidence of high-degree autoheparinization, and these patients had higher Injury Severity Score (median [interquartile range], 31 [26-37] vs. 17 [10-26]), increased glucose (median, 13.6 vs. 8.0 mmol/L), and lower hemoglobin level (median, 5.8 vs. 8.4 mmol/L) and received more transfusions during the first 1 hour (median, 5 vs. 0) and 24 hours (median, 10 vs. 0) (all p < 0.05). Importantly, patients with autoheparinization had fourfold higher syndecan 1 levels (median [interquartile range], 116 ng/mL [78-140 ng/mL] vs. 31 ng/mL [18-49 ng/mL]), and they had higher international normalized ratio (median, 1.4 vs. 1.1), thrombomodulin (median, 4.1 vs. 1.7 ng/mL) and interleukin 6 (median, 129 vs. 71 pg/mL) but lower protein C (85% vs. 109%) (all p < 0.05), indicating profound endothelial damage, coagulopathy and inflammation. CONCLUSION: Five percent of the patients with trauma in the present study had evidence of acute endogenous coagulopathy with autoheparinization by TEG, which appeared mechanistically linked to endothelial glycocalyx degradation. Acute endogenous autoheparinization may contribute to TIC. LEVEL OF EVIDENCE: Prognostic study, level III.
机译:背景:越来越多的证据表明,创伤早期诱发的凝血病(TIC)与血管内皮及其糖萼的破坏在机械上相关,分别由血栓调节蛋白和syndecan 1评估。这项研究评估了内皮糖萼的降解以及随之释放的肝素样物质是否诱导自身肝素化,从而促进了TIC。方法:前瞻性观察性研究对77名一级创伤中心收治的创伤患者进行了观察。记录有关人口统计学,血液学,损伤严重程度评分,输血要求,30天死亡率和血栓弹性成像(TEG,并发高岭土活化/高岭土肝素酶活化)的数据。对血浆/血清中反映内皮糖萼和细胞损伤(syndecan 1,血栓调节蛋白),组织损伤(组蛋白复合的DNA片段),交感肾上腺活化(肾上腺素,去甲肾上腺素),凝血活化/抗凝(凝血酶原片段1 + 2,纤维蛋白原,von Willebrand因子,XIII因子,抗凝血酶,蛋白C,活化的蛋白C,组织因子途径抑制剂),纤维蛋白溶解(组织型纤溶酶原激活物,纤溶酶原激活物抑制剂1)和炎症(白介素6,末端补体复合物)。根据TEG测量的肝素化程度将患者分层。结果:4例患者(5.2%)表现出高度自身肝素化的证据,这些患者的损伤严重度评分较高(中位[四分位间距],31 [26-37]比17 [10-26]),血糖升高(中位数分别为13.6和8.0 mmol / L)和较低的血红蛋白水平(中位数为5.8 vs. 8.4 mmol / L),并且在开始的1小时(中位数为5 vs. 0)和24小时内(中位数为10,输血更多) vs. 0)(所有p <0.05)。重要的是,自肝素化患者的syndecan 1水平提高了四倍(中位[四分位间距],116 ng / mL [78-140 ng / mL]与31 ng / mL [18-49 ng / mL]),并且他们的血红蛋白水平更高。国际标准化比率(中位数为1.4 vs. 1.1),血栓调节蛋白(中位数为4.1 vs. 1.7 ng / mL)和白介素6(中位数为129 vs. 71 pg / mL),但蛋白C较低(85%vs. 109%) (均p <0.05),表明发生了严重的内皮损伤,凝血病和炎症。结论:本研究中有5%的创伤患者有TEG自身肝素化引起的急性内源性凝血病的证据,其机制与内皮糖萼降解有关。急性内源性自肝素化可能会导致TIC。证据级别:预后研究,III级。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号